Quick Answer
AIM ImmunoTech Inc. reported Total Assets of $5.78 million for the year ending 2025.
- AIM ImmunoTech Inc. showed a decrease of -32.8% in Total Assets from 2024 to 2025.
- This data is from AIM ImmunoTech Inc.'s annual report (Form 10-K), filed with the SEC on March 27, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: $47.60 million | Q3 2011: $45.54 million | Q1 2012: $42.73 million | Q2 2012: $41.11 million | Q3 2012: $48.58 million | Q1 2013: $51.66 million | Q2 2013: $46.14 million | Q3 2013: $42.88 million | Q1 2014: $35.01 million | Q2 2014: $33.55 million | Q3 2014: $30.64 million | Q1 2015: $30.79 million | Q2 2015: $29.87 million | Q3 2015: $26.50 million | Q1 2016: $21.50 million | Q2 2016: $21.92 million | Q3 2016: $21.58 million | Q1 2017: $16.86 million | Q2 2017: $16.11 million | Q3 2017: $14.73 million | Q1 2018: $16.26 million | Q2 2018: $15.69 million | Q3 2018: $15.17 million | Q1 2019: $15.97 million | Q2 2019: $13.81 million | Q3 2019: $22.49 million | Q1 2020: $42.41 million | Q2 2020: $50.12 million | Q3 2020: $64.16 million | Q1 2021: $74.09 million | Q2 2021: $66.72 million | Q3 2021: $63.08 million | Q1 2022: $54.16 million | Q2 2022: $50.88 million | Q3 2022: $46.29 million | Q1 2023: $37.46 million | Q2 2023: $33.62 million | Q3 2023: $27.86 million | Q1 2024: $16.19 million | Q2 2024: $15.72 million | Q3 2024: $13.59 million | Q1 2025: $6.25 million | Q2 2025: $4.13 million | Q3 2025: $5.49 million.
- Over the full 16 years of available data (2010 to 2025), AIM ImmunoTech Inc.'s Total Assets has declined by 88.8%.
- Historical annual values: Fiscal year 2025: $5.78 million | Fiscal year 2024: $8.61 million | Fiscal year 2023: $19.38 million | Fiscal year 2022: $40.49 million | Fiscal year 2021: $57.70 million | Fiscal year 2020: $64.58 million | Fiscal year 2019: $20.75 million | Fiscal year 2018: $13.85 million | Fiscal year 2017: $14.21 million | Fiscal year 2016: $18.87 million | Fiscal year 2015: $22.80 million | Fiscal year 2014: $29.44 million | Fiscal year 2013: $31.87 million | Fiscal year 2012: $57.70 million | Fiscal year 2011: $43.51 million | Fiscal year 2010: $51.68 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: